The transition from timed intercourse to IUI is one of the most common escalation decisions in fertility treatment, and one of the least clearly explained. When the data supports the move, hesitating costs time. When the data does not, escalating prematurely adds cost and stress without improving odds. This is the decision framework by the numbers.
What IUI Actually Adds Over Timed Intercourse
Timed intercourse (TI) relies on natural sperm transport through the cervix and into the fallopian tube. IUI places washed, concentrated sperm directly into the uterus, bypassing the cervix and reducing the distance sperm must travel to reach the egg.
The absolute per-cycle pregnancy rate improvement from TI to IUI is modest: roughly 3 to 8 percentage points for most causes of subfertility. But the improvement is not uniform. It depends on the underlying cause:
| Scenario | TI per cycle | IUI per cycle | Lift |
|---|---|---|---|
| Unexplained infertility + letrozole | 7 to 10% | 10 to 15% | Modest |
| Cervical factor | 3 to 5% | 12 to 18% | Large (IUI bypasses the barrier) |
| Mild male factor (TMC 5 to 10M) | 5 to 8% | 10 to 14% | Moderate |
| Ovulatory disorder + letrozole | 15 to 20% | 15 to 20% | Minimal (ovulation was the issue, not transport) |
| Severe male factor (TMC below 5M) | 1 to 3% | 3 to 5% | Small (IVF with ICSI is more appropriate) |
The Key Insight
IUI adds the most value when the barrier to conception is transport (cervical factor, mild male factor, timing issues). It adds the least value when the barrier is egg quality, tubal disease, or severe sperm deficiency. Knowing your barrier determines whether IUI is the right escalation or a detour before IVF.
When the Evidence Says Move to IUI
The major fertility guidelines (ASRM, NICE, ESHRE) converge on these thresholds:
- After 3 to 6 medicated TI cycles without pregnancy in couples under 38 with unexplained infertility. The 2020 ASRM committee opinion recommends not exceeding 3 to 4 cycles of ovulation induction with TI before escalating.
- Immediately when cervical factor is suspected (normal workup but TI is not producing pregnancy and cervical mucus is scant or hostile).
- After confirming mild male factor on semen analysis. IUI concentrates and washes the sample, delivering a higher total motile count directly to the uterine cavity.
- When performance issues make timed intercourse unreliable and at-home insemination is not preferred or has not worked.
When the Evidence Says Skip IUI and Go to IVF
IUI is not always the right intermediate step. Going straight to IVF is more cost-effective and time-efficient in these situations:
- Age over 38 with diminished ovarian reserve (AMH below 1.0 ng/mL, AFC under 5 to 7). Time matters more than stepwise escalation at this point.
- Bilateral tubal disease. IUI requires at least one open tube.
- Severe male factor (TMC below 5 million post-wash). IUI success rates at this threshold are so low that IVF with ICSI is the evidence-based path.
- After 3 to 4 failed IUI cycles. The ASRM recommends against continuing beyond this threshold without reassessment, and the typical recommendation is to move to IVF.
- When both partners have multiple contributing factors (e.g., low reserve + mild male factor + age over 36). Combined sub-threshold impairments compound, and IVF addresses all of them simultaneously.
The Cost-Per-Pregnancy Math
IUI costs $500 to $1,500 per cycle (including monitoring and medications). IVF costs $12,000 to $25,000 per cycle. The instinct to "try IUI first because it's cheaper" is understandable but not always correct.
If your per-cycle IUI success rate is 10 percent, you need an average of 10 cycles to achieve pregnancy, for a cost-per-pregnancy of roughly $5,000 to $15,000. If your per-cycle IVF success rate is 45 percent (typical for patients under 35), you need an average of 2.2 cycles, for a cost-per-pregnancy of roughly $26,000 to $55,000.
But if your IUI success rate is only 3 to 5 percent (severe male factor, diminished reserve), the cost-per-pregnancy for IUI becomes $10,000 to $50,000, matching or exceeding IVF while taking far longer.
| Per-cycle IUI rate | Avg cycles needed | Cost range | Time (months) |
|---|---|---|---|
| 15% | ~6.7 | $3,350 to $10,050 | 6 to 7 |
| 10% | ~10 | $5,000 to $15,000 | 10 |
| 5% | ~20 | $10,000 to $30,000 | 20 |
The Decision Conversation with Your RE
The escalation decision should be explicit, not implied. Questions to ask:
- "Based on my diagnosis, what is my estimated per-cycle IUI success rate?"
- "How many IUI cycles do you recommend before reassessing?"
- "At what point would you recommend moving directly to IVF?"
- "Given my age and reserve, is IUI a reasonable use of time, or should we go straight to IVF?"
A good RE will give you numbers, not reassurances. The answer might be "IUI is a reasonable 3-cycle trial with your profile" or "Honestly, at your AMH level, I'd recommend IVF to maximize your window." Either answer is better than open-ended timed intercourse without a clear escalation timeline.
The Emotional Factor
Data-driven escalation is the medical recommendation, but the emotional toll of additional cycles matters too. If timed intercourse is damaging your relationship, your mental health, or your willingness to continue treatment, escalating to IUI or IVF before the "optimal" clinical threshold is a valid decision. Treatment adherence depends on being able to sustain the process.
The Age Factor in the Escalation Decision
Age does not just affect success rates. It changes how much time you can afford to spend at each escalation step. A 28-year-old with unexplained infertility can reasonably try 4 to 6 IUI cycles before moving to IVF because the per-cycle probability remains relatively stable and the time cost (6 months) does not significantly change the long-term prognosis. A 39-year-old in the same clinical situation does not have the same calculus.
Ovarian reserve declines continuously, and the decline accelerates after 37. Every month spent on a low-probability intervention is a month of further decline. The ASRM's 2023 committee opinion on unexplained infertility explicitly recommends a shorter escalation timeline for patients over 38: consider moving directly to IVF after 3 IUI cycles (or even skipping IUI entirely if AMH is below 1.0 ng/mL).
This is not ageism. It is a mathematical reality. The per-cycle IVF success rate at 39 is roughly 30 to 35 percent; at 42, it drops to 10 to 15 percent. Spending 6 months on IUI with a 10 percent per-cycle rate when IVF offers 30 percent is not conservative treatment. It is time-costly treatment.
IUI Protocol Variations and Their Success Rates
Not all IUI cycles are created equal. The protocol (which medications are paired with the insemination) significantly affects the per-cycle success rate:
- Natural cycle IUI (no medications): 5 to 8 percent per cycle. Used when ovulation is regular and the issue is purely cervical or mild male factor. The lowest-cost option but also the lowest-efficacy.
- Letrozole + IUI: 10 to 15 percent per cycle. The most common first-line protocol. Letrozole is preferred over Clomid because it does not have the anti-estrogenic cervical mucus side effects.
- Clomid + IUI: 8 to 12 percent per cycle. Still widely used but declining in favor of letrozole. The cervical mucus impairment from Clomid partially offsets the ovulation benefit, particularly in cervical factor patients.
- Gonadotropins + IUI: 15 to 25 percent per cycle. The highest-efficacy IUI protocol but also the most expensive ($1,500 to $4,000 per cycle including medications) and the highest multiples risk. Requires more intensive monitoring.
The AMIGOS trial (a 2018 randomized controlled trial published in the New England Journal of Medicine) compared gonadotropins + IUI, Clomid + IUI, and letrozole + IUI for unexplained infertility. Gonadotropin + IUI had the highest per-cycle pregnancy rate but also the highest multiple pregnancy rate (32 percent twins or higher). Letrozole + IUI had the best balance of efficacy and safety for most patients.
The Semen Analysis Numbers That Drive the Decision
The key semen parameter for IUI decision-making is the total motile sperm count (TMC) in the post-wash sample. This is different from the raw semen analysis numbers. Sperm washing concentrates motile sperm and removes seminal fluid, debris, and non-motile sperm.
- Post-wash TMC above 10 million: Good IUI candidacy. Per-cycle rates of 10 to 15 percent with ovulation induction.
- Post-wash TMC 5 to 10 million: Moderate candidacy. IUI still provides benefit over TI, but success rates are reduced (8 to 12 percent).
- Post-wash TMC below 5 million: Poor IUI candidacy. Per-cycle rates drop below 5 percent, making IVF with ICSI the more cost-effective and time-efficient path.
- Post-wash TMC below 1 million: IUI is not recommended. IVF with ICSI is the standard treatment.
If your semen analysis shows borderline numbers, ask your RE to do a test wash before your first IUI cycle. The test wash processes a sample through the IUI preparation protocol and reports the post-wash TMC, giving you a realistic preview of what the insemination sample will look like. This avoids the disappointment of committing to an IUI cycle only to find that the post-wash sample falls below the threshold.